Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer
============================================================================================================================================================================

* Jason M. Redman
* Seth M. Steinberg
* James L. Gulley